AMPFX
Price
$43.81
Change
+$0.31 (+0.71%)
Updated
Jun 6 closing price
Net Assets
89.78B
GAFFX
Price
$78.67
Change
+$0.76 (+0.98%)
Updated
Jun 6 closing price
Net Assets
304.87B
Interact to see
Advertisement

AMPFX vs GAFFX

Header iconAMPFX vs GAFFX Comparison
Open Charts AMPFX vs GAFFXBanner chart's image
American Funds AMCAP F1
Price$43.81
Change+$0.31 (+0.71%)
VolumeN/A
Net Assets89.78B
American Funds Growth Fund of Amer F3
Price$78.67
Change+$0.76 (+0.98%)
VolumeN/A
Net Assets304.87B
AMPFX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMPFX vs. GAFFX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPFX is a Buy and GAFFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 305B vs. AMPFX (89.8B). GAFFX pays higher dividends than AMPFX: GAFFX (0.65) vs AMPFX (0.31). AMPFX was incepted earlier than GAFFX: AMPFX (24 years) vs GAFFX (8 years). AMPFX (0.70) is less costly to investors than GAFFX (0.30). AMPFX is a more actively managed with annual turnover of: 36.00 vs. GAFFX (25.00). AMPFX has a lower initial minimum investment than GAFFX: AMPFX (250) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. AMPFX (5.20). GAFFX return over 5 years is better than : 47.05 vs. AMPFX (28.95).
AMPFXGAFFXAMPFX / GAFFX
Total Expense Ratio0.700.30233%
Annual Report Gross Expense Ratio0.700.30233%
Fund Existence24 years8 years-
Gain YTD3.8895.64069%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets89.8B305B29%
Annual Yield % from dividends0.310.6547%
Returns for 1 year5.209.7453%
Returns for 3 years27.1238.5670%
Returns for 5 years28.9547.0562%
Returns for 10 years51.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV14.360.56
+4.09%
KalVista Pharmaceuticals
BRC70.000.45
+0.65%
Brady Corp
PKX47.710.03
+0.06%
POSCO Holdings
SLS1.61-0.02
-1.23%
SELLAS Life Sciences Group
CNET1.26-0.06
-4.56%
ZW Data Action Technologies Inc